1. Agar dilution minimum inhibitory concentrations under-represent oritavancin in vitro activity against staphylococci and enterococci. (June 2017) Authors: Arhin, Francis F.; Moeck, Gregory Journal: Journal of global antimicrobial resistance Issue: Volume 9(2017) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of the potential for oritavancin MIC changes among Staphylococcus aureus nasal carriage isolates following systemic oritavancin treatment in a phase 2 study in patients with acute bacterial skin and skin-structure infections. (June 2017) Authors: Arhin, Francis F.; Moeck, Gregory Journal: Journal of global antimicrobial resistance Issue: Volume 9(2017) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗